S&P 500   2,718.34 (+2.05%)
DOW   23,172.22 (+2.17%)
QQQ   199.74 (+1.66%)
AAPL   263.68 (+0.46%)
FB   170.90 (+2.83%)
MSFT   166.74 (+0.89%)
GOOGL   1,197.42 (+1.20%)
AMZN   2,021.15 (+1.02%)
CGC   14.84 (+3.49%)
NVDA   265.95 (-0.91%)
BABA   199.38 (+1.49%)
MU   47.65 (+2.76%)
GE   7.28 (+0.69%)
TSLA   555.47 (+7.60%)
AMD   49.14 (+3.41%)
T   30.55 (+3.77%)
F   4.85 (+8.02%)
NFLX   376.35 (-0.95%)
BAC   22.56 (+5.47%)
GILD   74.82 (-3.74%)
DIS   103.11 (+3.54%)
S&P 500   2,718.34 (+2.05%)
DOW   23,172.22 (+2.17%)
QQQ   199.74 (+1.66%)
AAPL   263.68 (+0.46%)
FB   170.90 (+2.83%)
MSFT   166.74 (+0.89%)
GOOGL   1,197.42 (+1.20%)
AMZN   2,021.15 (+1.02%)
CGC   14.84 (+3.49%)
NVDA   265.95 (-0.91%)
BABA   199.38 (+1.49%)
MU   47.65 (+2.76%)
GE   7.28 (+0.69%)
TSLA   555.47 (+7.60%)
AMD   49.14 (+3.41%)
T   30.55 (+3.77%)
F   4.85 (+8.02%)
NFLX   376.35 (-0.95%)
BAC   22.56 (+5.47%)
GILD   74.82 (-3.74%)
DIS   103.11 (+3.54%)
S&P 500   2,718.34 (+2.05%)
DOW   23,172.22 (+2.17%)
QQQ   199.74 (+1.66%)
AAPL   263.68 (+0.46%)
FB   170.90 (+2.83%)
MSFT   166.74 (+0.89%)
GOOGL   1,197.42 (+1.20%)
AMZN   2,021.15 (+1.02%)
CGC   14.84 (+3.49%)
NVDA   265.95 (-0.91%)
BABA   199.38 (+1.49%)
MU   47.65 (+2.76%)
GE   7.28 (+0.69%)
TSLA   555.47 (+7.60%)
AMD   49.14 (+3.41%)
T   30.55 (+3.77%)
F   4.85 (+8.02%)
NFLX   376.35 (-0.95%)
BAC   22.56 (+5.47%)
GILD   74.82 (-3.74%)
DIS   103.11 (+3.54%)
S&P 500   2,718.34 (+2.05%)
DOW   23,172.22 (+2.17%)
QQQ   199.74 (+1.66%)
AAPL   263.68 (+0.46%)
FB   170.90 (+2.83%)
MSFT   166.74 (+0.89%)
GOOGL   1,197.42 (+1.20%)
AMZN   2,021.15 (+1.02%)
CGC   14.84 (+3.49%)
NVDA   265.95 (-0.91%)
BABA   199.38 (+1.49%)
MU   47.65 (+2.76%)
GE   7.28 (+0.69%)
TSLA   555.47 (+7.60%)
AMD   49.14 (+3.41%)
T   30.55 (+3.77%)
F   4.85 (+8.02%)
NFLX   376.35 (-0.95%)
BAC   22.56 (+5.47%)
GILD   74.82 (-3.74%)
DIS   103.11 (+3.54%)
Log in

OTCMKTS:RSLSReshape Lifesciences Stock Price, Forecast & News

$4.50
0.00 (0.00 %)
(As of 04/7/2020 01:56 PM ET)
Add
Compare
Today's Range
$4.50
Now: $4.50
$4.50
50-Day Range
$3.70
MA: $5.74
$7.85
52-Week Range
$2.91
Now: $4.50
$26.40
Volume15 shs
Average Volume640 shs
Market Capitalization$1.58 million
P/E RatioN/A
Dividend YieldN/A
Beta1.59
ReShape Lifesciences Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology, vBloc Therapy is designed to intermittently block the vagus nerve using electrical impulses. The company's product portfolio includes ReShape vBloc, a therapy that enables patients to feel full and eat less by intermittently blocking hunger signals on the vagus nerve; and ReShape Balloon system that uses balloon technology designed to take up room in the stomach to enable people lose weight. Its product portfolio also comprises ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without permanently changing patient anatomy. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in October 2017. ReShape Lifesciences Inc. was founded in 2002 and is headquartered in San Clemente, California.
Read More
Reshape Lifesciences logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.23 out of 5 stars


Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolOTCMKTS:RSLS
CUSIP29365M20
Phone949-429-6680

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$610,000.00
Cash Flow$64.29 per share
Book Value$341.84 per share

Profitability

Net Income$-81,150,000.00
Net Margins-668.58%

Miscellaneous

EmployeesN/A
Market Cap$1.58 million
Next Earnings Date5/18/2020 (Estimated)
OptionableNot Optionable

Receive RSLS News and Ratings via Email

Sign-up to receive the latest news and ratings for RSLS and its competitors with MarketBeat's FREE daily newsletter.


Reshape Lifesciences (OTCMKTS:RSLS) Frequently Asked Questions

How has Reshape Lifesciences' stock been impacted by COVID-19 (Coronavirus)?

Reshape Lifesciences' stock was trading at $5.55 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, RSLS shares have decreased by 18.9% and is now trading at $4.50. View which stocks have been mosted impacted by Coronavirus.

When is Reshape Lifesciences' next earnings date?

Reshape Lifesciences is scheduled to release its next quarterly earnings announcement on Monday, May 18th 2020. View our earnings forecast for Reshape Lifesciences.

How were Reshape Lifesciences' earnings last quarter?

Reshape Lifesciences Inc (OTCMKTS:RSLS) announced its quarterly earnings results on Tuesday, August, 14th. The medical device company reported ($672.00) earnings per share for the quarter, missing analysts' consensus estimates of ($250.60) by $421.40. The medical device company had revenue of $0.65 million for the quarter. Reshape Lifesciences had a negative net margin of 668.58% and a negative return on equity of 163.22%. View Reshape Lifesciences' earnings history.

When did Reshape Lifesciences' stock split? How did Reshape Lifesciences' stock split work?

Shares of Reshape Lifesciences reverse split on Thursday, November 8th 2018. The 1-140 reverse split was announced on Wednesday, November 7th 2018. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, November 7th 2018. An investor that had 100 shares of Reshape Lifesciences stock prior to the reverse split would have 1 shares after the split.

Has Reshape Lifesciences been receiving favorable news coverage?

Press coverage about RSLS stock has trended very negative on Tuesday, InfoTrie Sentiment reports. The research firm identifies positive and negative news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Reshape Lifesciences earned a media sentiment score of -3.3 on InfoTrie's scale. They also assigned media coverage about the medical device company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near future. View the latest news aboutReshape Lifesciences.

Who are some of Reshape Lifesciences' key competitors?

What other stocks do shareholders of Reshape Lifesciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Reshape Lifesciences investors own include XOMA (XOMA), Synergy Pharmaceuticals (SGYP), CTI BioPharma (CTIC), DryShips (DRYS), La Jolla Pharmaceutical (LJPC), Neovasc (NVCN), Gilead Sciences (GILD), Progenics Pharmaceuticals (PGNX), Clovis Oncology (CLVS) and Inovio Pharmaceuticals (INO).

Who are Reshape Lifesciences' key executives?

Reshape Lifesciences' management team includes the following people:
  • Mr. Dan W. Gladney, Chairman, Pres & CEO (Age 65)
  • Mr. Scott P. Youngstrom, CFO, Sr. VP of Fin. & Sec. (Age 58)
  • Mr. Naqeeb A. Ansari, VP of Worldwide Sales (Age 57)
  • Dr. Mark B. Knudson Ph.D., Co-Founder and Special Advisor to the CEO (Age 69)
  • Dr. Katherine S. Tweden Ph.D., Co-Founder (Age 57)

What is Reshape Lifesciences' stock symbol?

Reshape Lifesciences trades on the OTCMKTS under the ticker symbol "RSLS."

How do I buy shares of Reshape Lifesciences?

Shares of RSLS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Reshape Lifesciences' stock price today?

One share of RSLS stock can currently be purchased for approximately $4.50.

How big of a company is Reshape Lifesciences?

Reshape Lifesciences has a market capitalization of $1.58 million and generates $610,000.00 in revenue each year.  View additional information about Reshape Lifesciences.

What is Reshape Lifesciences' official website?

The official website for Reshape Lifesciences is http://www.reshapelifesciences.com/.

How can I contact Reshape Lifesciences?

Reshape Lifesciences' mailing address is 1001 Calle Amanecer, Clemente CA, 92673. The medical device company can be reached via phone at 949-429-6680 or via email at [email protected]

This page was last updated on 4/7/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel